Signature Genomics Lab Gets NY State Clinical Lab Permit | GenomeWeb

NEW YORK (GenomeWeb News) – Signature Genomics Laboratories has received its New York Clinical Laboratory Permit, allowing the firm to receive specimens drawn by clinical laboratories in the state of New York for testing.

The Spokane, Wash.-based firm said today that it is the first laboratory to receive a New York permit to perform microarray-based comparative genomic hybridization. It uses the technology, called SignatureChip, for the genetic evaluation of individuals with unexplained mental retardation and birth defects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.